Axsome Therapeutics, Inc. (AXSM)
USD 93.6
(-5.32%)
USD 93.6
(-5.32%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -239.23 Million USD | -20.97% |
| 2022 | -197.76 Million USD | -46.56% |
| 2021 | -134.94 Million USD | -28.04% |
| 2020 | -105.38 Million USD | -51.23% |
| 2019 | -69.68 Million USD | -125.05% |
| 2018 | -30.96 Million USD | -6.99% |
| 2017 | -28.94 Million USD | -6.4% |
| 2016 | -27.2 Million USD | -157.6% |
| 2015 | -10.55 Million USD | -75.98% |
| 2014 | -6 Million USD | -176.95% |
| 2013 | -2.16 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -79.34 Million USD | -16.07% |
| 2024 Q1 | -68.35 Million USD | 30.71% |
| 2023 Q3 | -62.19 Million USD | 7.4% |
| 2023 Q4 | -98.65 Million USD | -58.61% |
| 2023 Q1 | -11.21 Million USD | 83.2% |
| 2023 FY | -239.23 Million USD | -20.97% |
| 2023 Q2 | -67.17 Million USD | -498.77% |
| 2022 Q3 | -47.23 Million USD | -10.27% |
| 2022 Q2 | -42.83 Million USD | -4.54% |
| 2022 Q1 | -40.97 Million USD | -20.6% |
| 2022 FY | -197.76 Million USD | -46.56% |
| 2022 Q4 | -66.76 Million USD | -41.34% |
| 2021 Q4 | -33.97 Million USD | 2.6% |
| 2021 FY | -134.94 Million USD | -28.04% |
| 2021 Q3 | -34.88 Million USD | -8.05% |
| 2021 Q2 | -32.28 Million USD | -10.34% |
| 2021 Q1 | -29.25 Million USD | -0.33% |
| 2020 Q4 | -29.16 Million USD | -27.22% |
| 2020 FY | -105.38 Million USD | -51.23% |
| 2020 Q1 | -32.48 Million USD | -30.95% |
| 2020 Q2 | -18.32 Million USD | 43.58% |
| 2020 Q3 | -22.92 Million USD | -25.09% |
| 2019 Q3 | -19.13 Million USD | -39.04% |
| 2019 FY | -69.68 Million USD | -125.05% |
| 2019 Q4 | -24.8 Million USD | -29.64% |
| 2019 Q2 | -13.76 Million USD | -29.34% |
| 2019 Q1 | -10.64 Million USD | -10.87% |
| 2018 Q4 | -9.59 Million USD | -15.88% |
| 2018 Q2 | -8.28 Million USD | -72.32% |
| 2018 Q1 | -4.8 Million USD | 35.33% |
| 2018 FY | -30.96 Million USD | -6.99% |
| 2018 Q3 | -8.28 Million USD | -0.01% |
| 2017 Q4 | -7.43 Million USD | -15.5% |
| 2017 Q3 | -6.43 Million USD | 9.19% |
| 2017 Q1 | -7.99 Million USD | -9.09% |
| 2017 FY | -28.94 Million USD | -6.4% |
| 2017 Q2 | -7.08 Million USD | 11.39% |
| 2016 FY | -27.2 Million USD | -157.6% |
| 2016 Q4 | -7.32 Million USD | -1.87% |
| 2016 Q3 | -7.19 Million USD | -5.61% |
| 2016 Q2 | -6.81 Million USD | -16.13% |
| 2016 Q1 | -5.86 Million USD | -242.25% |
| 2015 Q1 | -2.14 Million USD | -43.7% |
| 2015 Q4 | -1.71 Million USD | 62.55% |
| 2015 Q2 | -2.12 Million USD | 0.5% |
| 2015 Q3 | -4.57 Million USD | -114.9% |
| 2015 FY | -10.55 Million USD | -75.98% |
| 2014 Q3 | -253.11 Thousand USD | 88.11% |
| 2014 Q1 | -2.12 Million USD | 0.0% |
| 2014 FY | -6 Million USD | -176.95% |
| 2014 Q4 | -1.48 Million USD | -488.37% |
| 2014 Q2 | -2.12 Million USD | 0.0% |
| 2013 FY | -2.16 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AbCellera Biologics Inc. | -146.39 Million USD | -63.416% |
| Alkermes plc | 355.75 Million USD | 167.248% |
| Agenus Inc. | -245.76 Million USD | 2.654% |
| Aptorum Group Limited | -2.82 Million USD | -8369.66% |
| Ardelyx, Inc. | -66.06 Million USD | -262.114% |
| Dyadic International, Inc. | -6.79 Million USD | -3420.556% |
| Eton Pharmaceuticals, Inc. | -936 Thousand USD | -25459.615% |
| Lantern Pharma Inc. | -15.96 Million USD | -1398.841% |
| Inhibikase Therapeutics, Inc. | -19.02 Million USD | -1157.236% |
| Novavax, Inc. | -545.06 Million USD | 56.108% |
| Janux Therapeutics, Inc. | -58.29 Million USD | -310.406% |
| Pyxis Oncology, Inc. | -73.79 Million USD | -224.215% |
| TransCode Therapeutics, Inc. | -18.54 Million USD | -1189.964% |
| Ocuphire Pharma, Inc. | -9.98 Million USD | -2295.734% |
| Outlook Therapeutics, Inc. | -58.98 Million USD | -305.607% |
| Madrigal Pharmaceuticals, Inc. | -373.63 Million USD | 35.969% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -882.929% |
| SELLAS Life Sciences Group, Inc. | -37.34 Million USD | -540.702% |
| Syros Pharmaceuticals, Inc. | -164.57 Million USD | -45.368% |
| Barinthus Biotherapeutics plc | -73.34 Million USD | -226.173% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | -1079.035% |
| Xeris Biopharma Holdings, Inc. | -62.25 Million USD | -284.287% |
| Clearside Biomedical, Inc. | -32.48 Million USD | -636.457% |
| C4 Therapeutics, Inc. | -132.49 Million USD | -80.567% |
| Alnylam Pharmaceuticals, Inc. | -440.24 Million USD | 45.658% |
| AlloVir, Inc. | -190.41 Million USD | -25.638% |
| Arrowhead Pharmaceuticals, Inc. | -205.27 Million USD | -16.545% |
| VYNE Therapeutics Inc. | -28.45 Million USD | -740.848% |
| Bicycle Therapeutics plc | -180.66 Million USD | -32.422% |
| BioXcel Therapeutics, Inc. | -179.05 Million USD | -33.613% |
| ChromaDex Corporation | -4.93 Million USD | -4744.836% |
| Chimerix, Inc. | -82.09 Million USD | -191.416% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.6 Million USD | -436.368% |
| Caribou Biosciences, Inc. | -102.07 Million USD | -134.386% |
| CRISPR Therapeutics AG | -153.61 Million USD | -55.744% |
| Precision BioSciences, Inc. | -61.31 Million USD | -290.153% |
| Fate Therapeutics, Inc. | -160.92 Million USD | -48.662% |
| Fortress Biotech, Inc. | -60.63 Million USD | -294.541% |
| Fortress Biotech, Inc. | -60.63 Million USD | -294.541% |
| HOOKIPA Pharma Inc. | -81.58 Million USD | -193.256% |
| ImmuCell Corporation | -5.77 Million USD | -4042.938% |
| IDEAYA Biosciences, Inc. | -112.96 Million USD | -111.788% |
| Immix Biopharma, Inc. | -15.42 Million USD | -1450.87% |
| Incyte Corporation | 597.59 Million USD | 140.033% |
| Innoviva, Inc. | 179.72 Million USD | 233.116% |
| IO Biotech, Inc. | -86.08 Million USD | -177.916% |
| Jaguar Health, Inc. | -41.3 Million USD | -479.269% |
| Keros Therapeutics, Inc. | -152.99 Million USD | -56.373% |
| Ligand Pharmaceuticals Incorporated | 52.15 Million USD | 558.715% |
| ContextLogic Inc. | -317 Million USD | 24.531% |
| MiMedx Group, Inc. | 67.43 Million USD | 454.747% |
| MEI Pharma, Inc. | 17.77 Million USD | 1445.697% |
| NextCure, Inc. | -62.72 Million USD | -281.42% |
| Onconetix, Inc. | -37.4 Million USD | -539.508% |
| Oncternal Therapeutics, Inc. | -39.47 Million USD | -505.988% |
| Opthea Limited | -220.24 Million USD | -8.625% |
| Psyence Biomedical Ltd. | -51.15 Million USD | -367.636% |
| Vaxcyte, Inc. | -402.26 Million USD | 40.527% |
| PDS Biotechnology Corporation | -42.94 Million USD | -457.116% |
| Precigen, Inc. | -95.9 Million USD | -149.456% |
| Pharming Group N.V. | -10.54 Million USD | -2168.089% |
| Phathom Pharmaceuticals, Inc. | -201.59 Million USD | -18.674% |
| Pieris Pharmaceuticals, Inc. | -24.54 Million USD | -874.771% |
| PureTech Health plc | -65.69 Million USD | -264.154% |
| Rigel Pharmaceuticals, Inc. | -25.09 Million USD | -853.481% |
| Avidity Biosciences, Inc. | -212.22 Million USD | -12.731% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.33 Million USD | -882.929% |
| Sangamo Therapeutics, Inc. | -257.83 Million USD | 7.211% |
| Sol-Gel Technologies Ltd. | -27.23 Million USD | -778.324% |
| Acelyrin, Inc. | -381.64 Million USD | 37.313% |
| Salarius Pharmaceuticals, Inc. | -12.54 Thousand USD | -1907289.882% |
| Summit Therapeutics Inc. | -614.92 Million USD | 61.095% |
| Sensei Biotherapeutics, Inc. | -34.1 Million USD | -601.557% |
| Senti Biosciences, Inc. | -92.91 Million USD | -157.469% |
| Stoke Therapeutics, Inc. | -104.69 Million USD | -128.501% |
| Elevation Oncology, Inc. | -45.7 Million USD | -423.451% |
| Alaunos Therapeutics, Inc. | -35.14 Million USD | -580.814% |
| Telomir Pharmaceuticals, Inc. Common Stock | -13.07 Million USD | -1730.175% |
| Entrada Therapeutics, Inc. | -6.68 Million USD | -3478.728% |
| VistaGen Therapeutics, Inc. | -29.36 Million USD | -714.788% |
| Kintara Therapeutics, Inc. | -8.5 Million USD | -2714.234% |
| Wave Life Sciences Ltd. | -57.51 Million USD | -315.972% |
| Seer, Inc. | -86.27 Million USD | -177.291% |
| Verrica Pharmaceuticals Inc. | -66.99 Million USD | -257.098% |
| Aadi Bioscience, Inc. | -65.76 Million USD | -263.777% |
| ESSA Pharma Inc. | -26.58 Million USD | -799.988% |
| GlycoMimetics, Inc. | -36.89 Million USD | -548.352% |
| GT Biopharma, Inc. | -7.59 Million USD | -3049.111% |
| Inhibrx Biosciences, Inc. | -241.36 Million USD | 0.88% |
| Akebia Therapeutics, Inc. | -51.92 Million USD | -360.738% |
| Catalyst Pharmaceuticals, Inc. | 71.41 Million USD | 435.02% |
| Longboard Pharmaceuticals, Inc. | -54.42 Million USD | -339.598% |
| Orchestra BioMed Holdings, Inc. | -49.12 Million USD | -387.048% |
| Alzamend Neuro, Inc. | -9.94 Million USD | -2304.947% |
| Sorrento Therapeutics, Inc. | -572.84 Million USD | 58.237% |
| TRACON Pharmaceuticals, Inc. | -3.58 Million USD | -6567.726% |
| Viracta Therapeutics, Inc. | -51.05 Million USD | -368.561% |
| Rocket Pharmaceuticals, Inc. | -245.59 Million USD | 2.588% |
| Aptose Biosciences Inc. | -51.2 Million USD | -367.198% |
| ZyVersa Therapeutics, Inc. | -98.29 Million USD | -143.38% |
| Soligenix, Inc. | -6.14 Million USD | -3795.921% |
| Century Therapeutics, Inc. | -136.67 Million USD | -75.044% |
| Kura Oncology, Inc. | -152.63 Million USD | -56.743% |
| TScan Therapeutics, Inc. | -89.21 Million USD | -168.15% |
| Intensity Therapeutics, Inc. | -10.53 Million USD | -2170.241% |
| Ocean Biomedical, Inc. | 565.47 Thousand USD | 42407.815% |
| CytomX Therapeutics, Inc. | -569 Thousand USD | -41945.343% |
| Autolus Therapeutics plc | -208.38 Million USD | -14.807% |
| Mineralys Therapeutics, Inc. | -71.89 Million USD | -232.746% |
| EyePoint Pharmaceuticals, Inc. | -70.79 Million USD | -237.931% |
| Eterna Therapeutics Inc. | -21.66 Million USD | -1004.107% |
| Adaptive Biotechnologies Corporation | -225.25 Million USD | -6.21% |
| GRI Bio, Inc. | -13.03 Million USD | -1735.069% |
| Xenetic Biosciences, Inc. | -4.13 Million USD | -5686.274% |
| Tenaya Therapeutics, Inc. | -124.08 Million USD | -92.803% |
| IGM Biosciences, Inc. | -246.41 Million USD | 2.913% |
| INmune Bio, Inc. | -30 Million USD | -697.247% |
| Heron Therapeutics, Inc. | -110.55 Million USD | -116.389% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -466.998% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1398.829% |
| Entero Therapeutics, Inc. | -15.79 Million USD | -1414.646% |
| Milestone Pharmaceuticals Inc. | -59.68 Million USD | -300.834% |
| X4 Pharmaceuticals, Inc. | -101.16 Million USD | -136.478% |
| Atara Biotherapeutics, Inc. | -276.12 Million USD | 13.359% |
| Coherus BioSciences, Inc. | -237.89 Million USD | -0.566% |
| Verastem, Inc. | -87.36 Million USD | -173.831% |
| Abeona Therapeutics Inc. | -54.18 Million USD | -341.496% |
| Pliant Therapeutics, Inc. | -161.33 Million USD | -48.286% |
| Tonix Pharmaceuticals Holding Corp. | -116.65 Million USD | -105.076% |
| Histogen Inc. | -10.62 Million USD | -2152.5% |
| Aprea Therapeutics, Inc. | -14.28 Million USD | -1574.544% |
| Surrozen, Inc. | -43.04 Million USD | -455.825% |
| Organovo Holdings, Inc. | -14.67 Million USD | -1530.686% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -4602.902% |
| Ovid Therapeutics Inc. | -52.33 Million USD | -357.094% |
| Panbela Therapeutics, Inc. | -25.26 Million USD | -846.99% |
| CASI Pharmaceuticals, Inc. | -26.93 Million USD | -788.106% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.35 Million USD | -2762.696% |
| Centessa Pharmaceuticals plc | -151.08 Million USD | -58.347% |
| Hepion Pharmaceuticals, Inc. | -48.92 Million USD | -388.979% |
| Arcturus Therapeutics Holdings Inc. | -29.72 Million USD | -704.838% |
| BioRestorative Therapies, Inc. | -10.41 Million USD | -2196.456% |
| Apollomics, Inc. | -172.6 Million USD | -38.608% |
| Amarin Corporation plc | -59.11 Million USD | -304.72% |
| Mesoblast Limited | -87.95 Million USD | -171.997% |
| Turnstone Biologics Corp. | -55.2 Million USD | -333.402% |
| Kymera Therapeutics, Inc. | -146.96 Million USD | -62.789% |
| Synaptogenix, Inc. | -6.03 Million USD | -3861.875% |
| Tiziana Life Sciences Ltd | -16.2 Million USD | -1376.049% |
| Aurinia Pharmaceuticals Inc. | -78.02 Million USD | -206.637% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4893.002% |
| Monopar Therapeutics Inc. | -8.4 Million USD | -2747.327% |
| Exelixis, Inc. | 207.76 Million USD | 215.148% |
| Better Therapeutics, Inc. | -39.76 Million USD | -501.705% |
| Nurix Therapeutics, Inc. | -143.94 Million USD | -66.198% |
| Apellis Pharmaceuticals, Inc. | -528.62 Million USD | 54.744% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1865.473% |
| Dermata Therapeutics, Inc. | -7.79 Million USD | -2969.243% |
| Aridis Pharmaceuticals, Inc. | -30.74 Million USD | -678.035% |
| Gritstone bio, Inc. | -138.49 Million USD | -72.747% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -271.113% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -5881.025% |
| Avid Bioservices, Inc. | -140.75 Million USD | -69.97% |
| Insmed Incorporated | -749.56 Million USD | 68.083% |
| Virpax Pharmaceuticals, Inc. | -15.18 Million USD | -1475.021% |
| MediWound Ltd. | -6.71 Million USD | -3462.21% |
| OmniAb, Inc. | -50.61 Million USD | -372.625% |
| Alector, Inc. | -130.39 Million USD | -83.477% |
| Seres Therapeutics, Inc. | -113.72 Million USD | -110.367% |
| Checkpoint Therapeutics, Inc. | -51.84 Million USD | -361.431% |
| Zai Lab Limited | -334.62 Million USD | 28.505% |
| Revance Therapeutics, Inc. | -323.98 Million USD | 26.158% |
| Aura Biosciences, Inc. | -76.4 Million USD | -213.106% |
| Lyell Immunopharma, Inc. | -234.63 Million USD | -1.963% |
| Immunic, Inc. | -93.61 Million USD | -155.563% |
| Tarsus Pharmaceuticals, Inc. | -135.89 Million USD | -76.049% |
| Veracyte, Inc. | -74.4 Million USD | -221.539% |
| InMed Pharmaceuticals Inc. | -7.67 Million USD | -3016.884% |
| FibroGen, Inc. | -284.23 Million USD | 15.83% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -812.008% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -3316.763% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.83 Million USD | -1170.333% |
| Jazz Pharmaceuticals plc | 414.83 Million USD | 157.671% |
| Cyclacel Pharmaceuticals, Inc. | -22.55 Million USD | -960.687% |
| Amylyx Pharmaceuticals, Inc. | 49.27 Million USD | 585.555% |
| TG Therapeutics, Inc. | 12.67 Million USD | 1987.926% |
| Galecto, Inc. | -38.34 Million USD | -523.844% |
| Calithera Biosciences, Inc. | -18.86 Million USD | -1168.091% |
| Fortrea Holdings Inc. | -3.4 Million USD | -6936.412% |
| KalVista Pharmaceuticals, Inc. | -126.64 Million USD | -88.906% |
| Aptevo Therapeutics Inc. | -17.41 Million USD | -1274.062% |
| XBiotech Inc. | -24.55 Million USD | -874.215% |
| Jasper Therapeutics, Inc. | -64.46 Million USD | -271.113% |
| Lyra Therapeutics, Inc. | -62.68 Million USD | -281.682% |
| Foghorn Therapeutics Inc. | -98.42 Million USD | -143.064% |
| Y-mAbs Therapeutics, Inc. | -21.42 Million USD | -1016.526% |
| Theravance Biopharma, Inc. | -55.19 Million USD | -333.457% |
| Ultragenyx Pharmaceutical Inc. | -606.63 Million USD | 60.563% |
| Metagenomi, Inc. Common Stock | -68.25 Million USD | -250.506% |
| Vaxxinity, Inc. | -56.93 Thousand USD | -420102.34% |
| BioCryst Pharmaceuticals, Inc. | -226.53 Million USD | -5.606% |
| Gain Therapeutics, Inc. | -22.26 Million USD | -974.381% |
| Cartesian Therapeutics, Inc. | -219.71 Million USD | -8.888% |
| NexImmune, Inc. | -32.34 Million USD | -639.658% |
| Creative Medical Technology Holdings, Inc. | -5.28 Million USD | -4425.388% |
| Marker Therapeutics, Inc. | -14.04 Million USD | -1603.259% |
| Regeneron Pharmaceuticals, Inc. | 3.95 Billion USD | 106.051% |
| Chemomab Therapeutics Ltd. | -24.22 Million USD | -887.73% |
| Scopus BioPharma Inc. | -11.6 Million USD | -1960.651% |
| RAPT Therapeutics, Inc. | -116.79 Million USD | -104.831% |
| Ainos, Inc. | -13.77 Million USD | -1637.316% |
| Pluri Inc. | -20.88 Million USD | -1045.337% |
| Prothena Corporation plc | -147.02 Million USD | -62.716% |
| Adaptimmune Therapeutics plc | -113.87 Million USD | -110.096% |
| Celularity Inc. | -196.29 Million USD | -21.877% |
| Rallybio Corporation | -74.56 Million USD | -220.849% |
| Cue Biopharma, Inc. | -50.73 Million USD | -371.563% |
| MeiraGTx Holdings plc | -84.02 Million USD | -184.716% |
| Omeros Corporation | -117.81 Million USD | -103.066% |
| Humacyte, Inc. | -110.77 Million USD | -115.966% |
| Immunocore Holdings plc | -55.28 Million USD | -332.72% |
| Cocrystal Pharma, Inc. | -17.98 Million USD | -1230.282% |
| Cidara Therapeutics, Inc. | -22.93 Million USD | -943.295% |
| Blueprint Medicines Corporation | -506.98 Million USD | 52.812% |
| CalciMedica, Inc. | -34.35 Million USD | -596.33% |
| Cabaletta Bio, Inc. | -67.67 Million USD | -253.51% |
| Marinus Pharmaceuticals, Inc. | -141.4 Million USD | -69.186% |
| Scholar Rock Holding Corporation | -165.78 Million USD | -44.303% |
| Sana Biotechnology, Inc. | -283.25 Million USD | 15.54% |
| Pulmatrix, Inc. | -14.12 Million USD | -1594.2% |
| Elicio Therapeutics, Inc. | -35.19 Million USD | -579.75% |
| Vigil Neuroscience, Inc. | -82.63 Million USD | -189.501% |
| Intellia Therapeutics, Inc. | -481.19 Million USD | 50.282% |
| Adlai Nortye Ltd. American Depositary Shares | -104.87 Million USD | -128.126% |
| Cytokinetics, Incorporated | -526.24 Million USD | 54.539% |
| Eloxx Pharmaceuticals, Inc. | -36.06 Million USD | -563.352% |
| Nutriband Inc. | -5.48 Million USD | -4261.428% |
| Protara Therapeutics, Inc. | -40.42 Million USD | -491.88% |
| Vor Biopharma Inc. | -117.86 Million USD | -102.98% |
| Roivant Sciences Ltd. | 4.34 Billion USD | 105.501% |
| Evogene Ltd. | -23.87 Million USD | -901.876% |
| ProKidney Corp. | -35.46 Million USD | -574.518% |
| Applied Therapeutics, Inc. | -119.76 Million USD | -99.76% |
| Hoth Therapeutics, Inc. | -7.84 Million USD | -2949.409% |
| BridgeBio Pharma, Inc. | -643.2 Million USD | 62.805% |
| CorMedix Inc. | -46.33 Million USD | -416.275% |
| BioLineRx Ltd. | -60.61 Million USD | -294.691% |
| Tango Therapeutics, Inc. | -101.74 Million USD | -135.137% |
| Galectin Therapeutics Inc. | -41.06 Million USD | -482.57% |
| Atai Life Sciences N.V. | -40.22 Million USD | -494.764% |
| Renovaro Biosciences Inc. | -80.65 Million USD | -196.637% |
| Aerovate Therapeutics, Inc. | -75.52 Million USD | -216.783% |
| Zentalis Pharmaceuticals, Inc. | -292.19 Million USD | 18.123% |
| Sagimet Biosciences Inc. | -27.87 Million USD | -758.222% |
| MediciNova, Inc. | -8.57 Million USD | -2691.082% |
| Praxis Precision Medicines, Inc. | -123.27 Million USD | -94.065% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2755.948% |
| GeoVax Labs, Inc. | -25.96 Million USD | -821.324% |
| Biomea Fusion, Inc. | -117.25 Million USD | -104.032% |
| PTC Therapeutics, Inc. | -626.6 Million USD | 61.82% |
| Mereo BioPharma Group plc | -29.46 Million USD | -711.912% |
| Cullinan Oncology, Inc. | -153.16 Million USD | -56.199% |
| Syndax Pharmaceuticals, Inc. | -209.36 Million USD | -14.271% |
| Absci Corporation | -110.56 Million USD | -116.376% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -693.493% |
| 4D Molecular Therapeutics, Inc. | -100.83 Million USD | -137.252% |
| Dyne Therapeutics, Inc. | -235.93 Million USD | -1.399% |
| Kiniksa Pharmaceuticals, Ltd. | 14.08 Million USD | 1798.651% |
| Ventyx Biosciences, Inc. | -192.96 Million USD | -23.982% |
| Allakos Inc. | -185.7 Million USD | -28.83% |
| Imunon, Inc. | -19.51 Million USD | -1125.92% |
| Fulcrum Therapeutics, Inc. | -97.33 Million USD | -145.788% |
| Corcept Therapeutics Incorporated | 106.14 Million USD | 325.399% |
| BioAtla, Inc. | -123.46 Million USD | -93.775% |
| NLS Pharmaceutics AG | -12.17 Million USD | -1865.473% |
| Bio-Path Holdings, Inc. | -16.07 Million USD | -1387.984% |
| Allogene Therapeutics, Inc. | -327.26 Million USD | 26.898% |
| Larimar Therapeutics, Inc. | -36.94 Million USD | -547.482% |
| XOMA Corporation | -40.83 Million USD | -485.922% |
| Kezar Life Sciences, Inc. | -101.87 Million USD | -134.846% |
| Cara Therapeutics, Inc. | -118.51 Million USD | -101.866% |
| aTyr Pharma, Inc. | -50.38 Million USD | -374.782% |
| Aligos Therapeutics, Inc. | -87.67 Million USD | -172.857% |
| Akero Therapeutics, Inc. | -151.75 Million USD | -57.643% |
| Viridian Therapeutics, Inc. | -237.73 Million USD | -0.633% |
| Eliem Therapeutics, Inc. | -35.11 Million USD | -581.221% |
| EyeGate Pharmaceuticals, Inc. | -8.09 Million USD | -2856.497% |
| Akari Therapeutics, Plc | -10 Million USD | -2290.468% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -355247.939% |
| Halozyme Therapeutics, Inc. | 281.59 Million USD | 184.958% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -3489.522% |
| UroGen Pharma Ltd. | -102.24 Million USD | -133.987% |
| Sutro Biopharma, Inc. | -106.79 Million USD | -124.02% |
| ZIVO Bioscience, Inc. | -7.77 Million USD | -2976.152% |
| Orgenesis Inc. | -55.36 Million USD | -332.142% |
| Entera Bio Ltd. | -8.88 Million USD | -2591.394% |
| GH Research PLC | -35.58 Million USD | -572.262% |
| Lisata Therapeutics, Inc. | -20.84 Million USD | -1047.975% |
| Reneo Pharmaceuticals, Inc. | -77.38 Million USD | -209.141% |
| Xencor, Inc. | -126.08 Million USD | -89.74% |
| 60 Degrees Pharmaceuticals, Inc. | -3.76 Million USD | -6253.078% |
| Replimune Group, Inc. | -215.79 Million USD | -10.864% |
| Coeptis Therapeutics Holdings, Inc. | -21.26 Million USD | -1024.95% |
| Vanda Pharmaceuticals Inc. | 2.5 Million USD | 9635.193% |
| Lexaria Bioscience Corp. | -6.66 Million USD | -3489.522% |
| Portage Biotech Inc. | -75.33 Million USD | -217.549% |
| Cardio Diagnostics Holdings, Inc. | -8.37 Million USD | -2755.948% |
| Olema Pharmaceuticals, Inc. | -96.65 Million USD | -147.517% |
| OncoCyte Corporation | -27.78 Million USD | -761.157% |
| Qualigen Therapeutics, Inc. | -13.41 Million USD | -1683.068% |
| Processa Pharmaceuticals, Inc. | -11.12 Million USD | -2051.127% |
| Purple Biotech Ltd. | -19.88 Million USD | -1103.41% |
| CollPlant Biotechnologies Ltd. | -7.01 Million USD | -3308.434% |
| scPharmaceuticals Inc. | -54.81 Million USD | -336.486% |
| ProMIS Neurosciences, Inc. | -17.5 Million USD | -1266.595% |
| HilleVax, Inc. | -123.56 Million USD | -93.612% |
| NeuroSense Therapeutics Ltd. | -10.1 Million USD | -2267.053% |
| Tharimmune, Inc. | -9.31 Million USD | -2467.181% |
| Genprex, Inc. | -30.86 Million USD | -675.225% |
| Neumora Therapeutics, Inc. Common Stock | -235.92 Million USD | -1.404% |
| Atossa Therapeutics, Inc. | -30.09 Million USD | -694.969% |
| XTL Biopharmaceuticals Ltd. | -1.78 Million USD | -13325.253% |
| Virios Therapeutics, Inc. | -5.29 Million USD | -4417.321% |
| OKYO Pharma Limited | -16.82 Thousand USD | -1421780.888% |
| Savara Inc. | -54.69 Million USD | -337.38% |
| Curis, Inc. | -47.41 Million USD | -404.583% |
| Daré Bioscience, Inc. | -30.16 Million USD | -693.193% |
| Carmell Therapeutics Corporation | -15.44 Million USD | -1448.959% |
| Titan Pharmaceuticals, Inc. | -5.56 Million USD | -4195.888% |
| Achieve Life Sciences, Inc. | -29.81 Million USD | -702.408% |
| BeiGene, Ltd. | -881.7 Million USD | 72.867% |
| Kiromic BioPharma, Inc. | -21.29 Million USD | -1023.5% |
| Revolution Medicines, Inc. Warrant | -436.36 Million USD | 45.175% |
| Protagonist Therapeutics, Inc. | -78.95 Million USD | -203.006% |
| Erasca, Inc. | -125.04 Million USD | -91.326% |
| bluebird bio, Inc. | -211.91 Million USD | -12.894% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -4684.284% |
| BioMarin Pharmaceutical Inc. | 167.64 Million USD | 242.705% |
| DBV Technologies S.A. | -72.72 Million USD | -228.958% |
| Protagenic Therapeutics, Inc. | -5 Million USD | -4684.284% |
| Moderna, Inc. | -4.71 Billion USD | 94.925% |
| Vincerx Pharma, Inc. | -40.15 Million USD | -495.757% |
| Fresh Tracks Therapeutics, Inc. | -5.69 Million USD | -4101.581% |
| Molecular Templates, Inc. | -8.12 Million USD | -2844.83% |
| Acrivon Therapeutics, Inc. Common Stock | -60.38 Million USD | -296.168% |
| Travere Therapeutics, Inc. | -111.39 Million USD | -114.758% |
| Monte Rosa Therapeutics, Inc. | -135.35 Million USD | -76.752% |
| Spruce Biosciences, Inc. | -47.91 Million USD | -399.255% |
| Celldex Therapeutics, Inc. | -141.42 Million USD | -69.158% |
| Cogent Biosciences, Inc. | -192.41 Million USD | -24.338% |
| MacroGenics, Inc. | -9.05 Million USD | -2541.179% |
| RenovoRx, Inc. | -10.23 Million USD | -2238.135% |
| Adicet Bio, Inc. | -142.65 Million USD | -67.7% |
| Prime Medicine, Inc. | -198.13 Million USD | -20.746% |
| Aditxt, Inc. | -32.38 Million USD | -638.826% |
| Adagene Inc. | -18.94 Million USD | -1162.712% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3171.978% |
| Quantum-Si incorporated | -95.96 Million USD | -149.31% |
| Maravai LifeSciences Holdings, Inc. | -119.02 Million USD | -100.991% |
| Acurx Pharmaceuticals, Inc. | -14.57 Million USD | -1541.115% |
| Voyager Therapeutics, Inc. | 132.33 Million USD | 280.789% |
| SciSparc Ltd. | -5.12 Million USD | -4570.793% |
| Vericel Corporation | -3.18 Million USD | -7418.479% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -198843.902% |
| Minerva Neurosciences, Inc. | -30 Million USD | -697.318% |
| Generation Bio Co. | -126.61 Million USD | -88.954% |
| Astria Therapeutics, Inc. | -72.89 Million USD | -228.213% |
| Black Diamond Therapeutics, Inc. | -82.44 Million USD | -190.189% |
| Arcutis Biotherapeutics, Inc. | -262.14 Million USD | 8.737% |
| Invivyd, Inc. | -198.64 Million USD | -20.436% |
| Relay Therapeutics, Inc. | -341.97 Million USD | 30.042% |
| Quoin Pharmaceuticals, Ltd. | -8.68 Million USD | -2654.113% |
| Spero Therapeutics, Inc. | 22.8 Million USD | 1149.013% |
| Artelo Biosciences, Inc. | -9.87 Million USD | -2322.909% |
| 2seventy bio, Inc. | -217.57 Million USD | -9.959% |
| ADMA Biologics, Inc. | -28.23 Million USD | -747.19% |
| Clene Inc. | -49.5 Million USD | -383.27% |
| Capricor Therapeutics, Inc. | -22.28 Million USD | -973.416% |
| Boundless Bio, Inc. Common Stock | -49.43 Million USD | -383.954% |
| GeoVax Labs, Inc. | -25.96 Million USD | -821.324% |
| Recursion Pharmaceuticals, Inc. | -328.06 Million USD | 27.076% |
| Citius Pharmaceuticals, Inc. | -32.54 Million USD | -635.146% |
| Contineum Therapeutics, Inc. Class A Common Stock | 22.72 Million USD | 1152.984% |
| Relmada Therapeutics, Inc. | -98.79 Million USD | -142.164% |
| Finch Therapeutics Group, Inc. | -74.75 Million USD | -220.034% |
| ALX Oncology Holdings Inc. | -160.8 Million USD | -48.775% |
| Vir Biotechnology, Inc. | -615.06 Million USD | 61.103% |
| Evaxion Biotech A/S | -22.12 Million USD | -981.302% |
| Ocular Therapeutix, Inc. | -80.73 Million USD | -196.321% |
| Verve Therapeutics, Inc. | -200.06 Million USD | -19.578% |
| Trevena, Inc. | -40.28 Million USD | -493.805% |
| Surrozen, Inc. | -43.04 Million USD | -455.825% |
| Tyra Biosciences, Inc. | -69.13 Million USD | -246.05% |
| Cingulate Inc. | -23.53 Million USD | -916.522% |
| Galmed Pharmaceuticals Ltd. | -6.91 Million USD | -3361.198% |
| Unity Biotechnology, Inc. | -39.86 Million USD | -500.196% |
| Tenax Therapeutics, Inc. | -7.71 Million USD | -3002.686% |
| Terns Pharmaceuticals, Inc. | -90.21 Million USD | -165.201% |
| ACADIA Pharmaceuticals Inc. | -61.28 Million USD | -290.363% |
| Connect Biopharma Holdings Limited | -59.5 Million USD | -302.06% |
| Clearmind Medicine Inc. | -11.95 Million USD | -1901.149% |
| Kronos Bio, Inc. | -112.67 Million USD | -112.329% |
| Bolt Biotherapeutics, Inc. | -69.19 Million USD | -245.735% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -9432719.579% |
| Viking Therapeutics, Inc. | -85.89 Million USD | -178.524% |
| Statera Biopharma, Inc. | -174.4 Million USD | -37.171% |
| ImmunityBio, Inc. | -583.19 Million USD | 58.978% |
| Korro Bio, Inc. | -81.17 Million USD | -194.73% |
| Kineta, Inc. | -14.09 Million USD | -1596.844% |
| BioVie Inc. | -32.12 Million USD | -644.813% |
| Codexis, Inc. | -76.24 Million USD | -213.796% |
| Celularity Inc. | -196.29 Million USD | -21.877% |
| Crinetics Pharmaceuticals, Inc. | -214.52 Million USD | -11.518% |
| Celcuity Inc. | -63.77 Million USD | -275.104% |
| Virax Biolabs Group Limited | -6.73 Million USD | -3452.932% |
| Cibus, Inc. | -267.62 Million USD | 10.608% |
| Eledon Pharmaceuticals, Inc. | -40.32 Million USD | -493.26% |
| eFFECTOR Therapeutics, Inc. | -35.81 Million USD | -568.057% |
| IN8bio, Inc. | -30 Million USD | -697.274% |
| Kodiak Sciences Inc. | -260.49 Million USD | 8.159% |
| Annexon, Inc. | -134.23 Million USD | -78.221% |
| Adverum Biotechnologies, Inc. | -117.16 Million USD | -104.189% |
| Assembly Biosciences, Inc. | -61.22 Million USD | -290.733% |
| Avalo Therapeutics, Inc. | -31.54 Million USD | -658.426% |
| Ionis Pharmaceuticals, Inc. | -366.28 Million USD | 34.685% |
| Eyenovia, Inc. | -27.26 Million USD | -777.58% |
| Puma Biotechnology, Inc. | 21.59 Million USD | 1208.045% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -44617.383% |
| Xilio Therapeutics, Inc. | -76.4 Million USD | -213.122% |
| Arcellx, Inc. | -70.69 Million USD | -238.433% |
| Cardiff Oncology, Inc. | -41.44 Million USD | -477.298% |
| Enanta Pharmaceuticals, Inc. | -133.81 Million USD | -78.781% |
| Regulus Therapeutics Inc. | -30.03 Million USD | -696.478% |
| Moolec Science SA | -51.78 Million USD | -361.949% |
| Acumen Pharmaceuticals, Inc. | -52.37 Million USD | -356.814% |
| Geron Corporation | -184.12 Million USD | -29.931% |
| LAVA Therapeutics N.V. | -41.97 Million USD | -469.967% |
| Royalty Pharma plc | 1.13 Billion USD | 121.081% |
| Atea Pharmaceuticals, Inc. | -135.95 Million USD | -75.967% |
| Greenwich LifeSciences, Inc. | -8.89 Million USD | -2590.545% |
| TFF Pharmaceuticals, Inc. | -21.24 Million USD | -1026.185% |
| Mersana Therapeutics, Inc. | -171.67 Million USD | -39.359% |
| Humacyte, Inc. | -110.77 Million USD | -115.966% |
| Structure Therapeutics Inc. | -89.62 Million USD | -166.947% |
| 89bio, Inc. | -142.18 Million USD | -68.254% |
| PMV Pharmaceuticals, Inc. | -68.96 Million USD | -246.923% |
| Avenue Therapeutics, Inc. | -10.37 Million USD | -2205.464% |
| Genelux Corporation | -28.29 Million USD | -745.454% |
| Trevi Therapeutics, Inc. | -29.06 Million USD | -723.114% |
| Lexicon Pharmaceuticals, Inc. | -177.11 Million USD | -35.072% |
| Notable Labs, Ltd. | -11.26 Million USD | -2023.917% |
| Liquidia Corporation | -78.5 Million USD | -204.754% |
| Mustang Bio, Inc. | -51.6 Million USD | -363.622% |
| Immunovant, Inc. | -259.33 Million USD | 7.75% |
| Quantum-Si incorporated | -95.96 Million USD | -149.31% |
| Arbutus Biopharma Corporation | -72.84 Million USD | -228.403% |
| DiaMedica Therapeutics Inc. | -19.38 Million USD | -1134.395% |
| Vera Therapeutics, Inc. | -95.99 Million USD | -149.232% |
| Acasti Pharma Inc. | -12.85 Million USD | -1761.34% |
| MiNK Therapeutics, Inc. | -22.45 Million USD | -965.275% |
| Pasithea Therapeutics Corp. | -15.96 Million USD | -1398.829% |
| Xenon Pharmaceuticals Inc. | -182.39 Million USD | -31.166% |
| Elevai Labs, Inc. Common Stock | -4.3 Million USD | -5461.712% |
| NeuroBo Pharmaceuticals, Inc. | -12.47 Million USD | -1818.508% |
| Tempest Therapeutics, Inc. | -29.49 Million USD | -711.224% |
| Soleno Therapeutics, Inc. | -38.98 Million USD | -513.62% |
| PepGen Inc. | -78.62 Million USD | -204.273% |
| Moleculin Biotech, Inc. | -29.76 Million USD | -703.648% |
| United Therapeutics Corporation | 984.8 Million USD | 124.293% |
| Nuvectis Pharma, Inc. | -22.26 Million USD | -974.744% |
| Solid Biosciences Inc. | -96.01 Million USD | -149.167% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -4893.002% |
| Immuneering Corporation | -53.47 Million USD | -347.411% |
| Lixte Biotechnology Holdings, Inc. | -5.08 Million USD | -4602.902% |
| Silo Pharma, Inc. | -3.7 Million USD | -6364.699% |
| Belite Bio, Inc | -31.63 Million USD | -656.316% |
| XOMA Corporation | -40.83 Million USD | -485.922% |
| ARS Pharmaceuticals, Inc. | -54.36 Million USD | -340.059% |
| Bionomics Limited | -15.49 Billion USD | 98.456% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -184.858% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -720.517% |
| uniQure N.V. | -308.47 Million USD | 22.446% |
| Cassava Sciences, Inc. | -97.21 Million USD | -146.087% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -3171.978% |
| Poseida Therapeutics, Inc. | -123.43 Million USD | -93.825% |
| Forte Biosciences, Inc. | -31.47 Million USD | -660.065% |
| Anebulo Pharmaceuticals, Inc. | -8.2 Million USD | -2816.931% |
| Enlivex Therapeutics Ltd. | -29.06 Million USD | -723.029% |
| Conduit Pharmaceuticals Inc. | -535 Thousand USD | -44617.383% |
| SeaStar Medical Holding Corporation | -26.23 Million USD | -812.008% |
| FibroBiologics, Inc. Common Stock | -16.48 Million USD | -1351.247% |
| Altimmune, Inc. | -88.44 Million USD | -170.487% |
| Amicus Therapeutics, Inc. | -151.58 Million USD | -57.825% |
| Alpha Tau Medical Ltd. | -29.15 Million USD | -720.517% |
| Compugen Ltd. | -18.75 Million USD | -1175.664% |
| Peak Bio, Inc. | -1259.26 USD | -18998200.589% |
| Zevra Therapeutics, Inc. | -46.04 Million USD | -419.529% |
| Benitec Biopharma Inc. | -21.75 Million USD | -999.894% |
| Spyre Therapeutics, Inc. | -338.79 Million USD | 29.385% |
| NKGen Biotech, Inc. Common Stock | -82.95 Million USD | -188.398% |
| Zura Bio Limited | -60.36 Million USD | -296.352% |
| PolyPid Ltd. | -23.86 Million USD | -902.464% |
| Aileron Therapeutics, Inc. | -15.73 Million USD | -1420.709% |
| NKGen Biotech, Inc. Warrants | -82.95 Million USD | -188.398% |
| Instil Bio, Inc. | -156.08 Million USD | -53.272% |
| argenx SE | -295.05 Million USD | 18.917% |
| Immunome, Inc. | -106.8 Million USD | -123.993% |
| Compass Therapeutics, Inc. | -42.49 Million USD | -462.992% |
| Verona Pharma plc | -54.36 Million USD | -340.026% |
| enGene Holdings Inc. Warrants | -99.91 Million USD | -139.437% |
| Shattuck Labs, Inc. | -87.29 Million USD | -174.048% |
| CervoMed Inc. | -2.17 Million USD | -10915.285% |
| LENZ Therapeutics, Inc. | -124.65 Million USD | -91.926% |
| Plus Therapeutics, Inc. | -13.31 Million USD | -1696.621% |
| Dianthus Therapeutics, Inc. | -43.55 Million USD | -449.278% |
| Moolec Science SA | -51.78 Million USD | -361.949% |
| Enveric Biosciences, Inc. | -17.29 Thousand USD | -1383439.993% |
| Inovio Pharmaceuticals, Inc. | -135.11 Million USD | -77.059% |
| AnaptysBio, Inc. | -163.61 Million USD | -46.217% |
| Design Therapeutics, Inc. | -66.86 Million USD | -257.809% |
| Leap Therapeutics, Inc. | -81.41 Million USD | -193.854% |
| NeurAxis, Inc. | -14.62 Million USD | -1535.627% |
| Seelos Therapeutics, Inc. | -37.88 Million USD | -531.535% |
| Lumos Pharma, Inc. | -34.03 Million USD | -602.938% |
| Achilles Therapeutics plc | -69.66 Million USD | -243.412% |
| enGene Holdings Inc. Common Stock | -99.91 Million USD | -139.437% |
| 180 Life Sciences Corp. | -19.93 Million USD | -1100.084% |
| Opiant Pharmaceuticals, Inc. | 3 Million USD | 8051.303% |
| CERo Therapeutics Holdings, Inc. | -2536.23 USD | -9432719.579% |
| Nutriband Inc. | -5.48 Million USD | -4261.428% |
| ORIC Pharmaceuticals, Inc. | -100.69 Million USD | -137.582% |
| CG Oncology, Inc. Common stock | -48.6 Million USD | -392.188% |
| Fractyl Health, Inc. Common Stock | -77.09 Million USD | -210.332% |
| Rani Therapeutics Holdings, Inc. | -33.97 Million USD | -604.263% |
| MoonLake Immunotherapeutics | -36 Million USD | -564.416% |
| Palisade Bio, Inc. | -12.3 Million USD | -1845.024% |
| Tourmaline Bio, Inc. | -42.12 Million USD | -467.938% |
| Beam Therapeutics Inc. | -132.52 Million USD | -80.52% |
| Neurogene Inc. | -36.31 Million USD | -558.749% |
| Mirum Pharmaceuticals, Inc. | -163.41 Million USD | -46.399% |
| AEON Biopharma, Inc. | -52.55 Million USD | -355.206% |
| CARGO Therapeutics, Inc. Common Stock | -98.14 Million USD | -143.755% |
| Sesen Bio, Inc. | -19.88 Million USD | -1103.168% |
| Enliven Therapeutics, Inc. | -71.58 Million USD | -234.206% |
| Kiora Pharmaceuticals, Inc. | -12.51 Million USD | -1811.779% |
| Iovance Biotherapeutics, Inc. | -444.03 Million USD | 46.122% |
| Taysha Gene Therapies, Inc. | -111.56 Million USD | -114.436% |
| Athira Pharma, Inc. | -117.67 Million USD | -103.309% |
| Vaccinex, Inc. | -20.25 Million USD | -1081.364% |
| HCW Biologics Inc. | -24.99 Million USD | -857.171% |
| XOMA Corporation | -40.83 Million USD | -485.922% |
| Nektar Therapeutics | -276.05 Million USD | 13.337% |
| Arvinas, Inc. | -367.3 Million USD | 34.866% |
| Tevogen Bio Holdings Inc. | -67.32 Thousand USD | -355247.939% |
| Merus N.V. | -154.93 Million USD | -54.408% |
| Omega Therapeutics, Inc. | -97.42 Million USD | -145.554% |
| Quince Therapeutics, Inc. | -31.38 Million USD | -662.269% |
| Rezolute, Inc. | -68.45 Million USD | -249.462% |
| Clene Inc. | -49.5 Million USD | -383.27% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -1451.129% |
| BeyondSpring Inc. | -21.02 Million USD | -1037.82% |
| Synlogic, Inc. | -57.28 Million USD | -317.65% |
| Allarity Therapeutics, Inc. | -11.9 Million USD | -1910.234% |
| Phio Pharmaceuticals Corp. | -10.82 Million USD | -2109.847% |
| Peak Bio, Inc. | -1259.26 USD | -18998200.589% |
| Werewolf Therapeutics, Inc. | -37.36 Million USD | -540.222% |
| Krystal Biotech, Inc. | 10.93 Million USD | 2288.419% |
| Karyopharm Therapeutics Inc. | -143.09 Million USD | -67.184% |
| SpringWorks Therapeutics, Inc. | -325.1 Million USD | 26.412% |
| Lipella Pharmaceuticals Inc. | -4.61 Million USD | -5079.472% |
| MannKind Corporation | -11.93 Million USD | -1904.004% |
| Ikena Oncology, Inc. | -68.16 Million USD | -250.964% |
| Cyclerion Therapeutics, Inc. | -21.01 Million USD | -1038.415% |
| Gyre Therapeutics, Inc. | -92.93 Million USD | -157.431% |
| Gossamer Bio, Inc. | -179.81 Million USD | -33.045% |
| CohBar, Inc. | -11.96 Million USD | -1899.963% |
| Cognition Therapeutics, Inc. | -25.78 Million USD | -827.711% |
| NRx Pharmaceuticals, Inc. | -30.15 Million USD | -693.493% |
| Legend Biotech Corporation | -518.25 Million USD | 53.838% |
| Mural Oncology plc | -207.44 Million USD | -15.325% |
| Biora Therapeutics, Inc. | -124.11 Million USD | -92.755% |
| PaxMedica, Inc. Common Stock | -18.28 Million USD | -1208.046% |
| Disc Medicine, Inc. | -76.42 Million USD | -213.02% |
| Champions Oncology, Inc. | -7.27 Million USD | -3188.043% |
| REGENXBIO Inc. | -263.49 Million USD | 9.206% |
| Ensysce Biosciences, Inc. | -10.61 Million USD | -2154.182% |
| Anavex Life Sciences Corp. | -47.5 Million USD | -403.606% |
| Cellectar Biosciences, Inc. | -37.98 Million USD | -529.847% |
| Edgewise Therapeutics, Inc. | -100.16 Million USD | -138.849% |
| Vaxart, Inc. | -82.46 Million USD | -190.109% |
| PharmaCyte Biotech, Inc. | 333.76 Thousand USD | 71779.006% |
| Aldeyra Therapeutics, Inc. | -37.54 Million USD | -537.246% |
| Cellectis S.A. | -101.05 Million USD | -136.731% |
| Longeveron Inc. | -21.41 Million USD | -1017.256% |
| Repare Therapeutics Inc. | -93.79 Million USD | -155.062% |
| Sarepta Therapeutics, Inc. | -535.97 Million USD | 55.364% |
| Inozyme Pharma, Inc. | -71.16 Million USD | -236.155% |
| Revolution Medicines, Inc. | -436.36 Million USD | 45.175% |
| Nymox Pharmaceutical Corporation | -6.57 Million USD | -3540.816% |
| Third Harmonic Bio, Inc. | -30.82 Million USD | -676.142% |
| ArriVent BioPharma, Inc. Common Stock | -69.33 Million USD | -245.056% |
| AN2 Therapeutics, Inc. | -64.73 Million USD | -269.582% |
| Anixa Biosciences, Inc. | -9.81 Million USD | -2338.467% |
| Vertex Pharmaceuticals Incorporated | 3.61 Billion USD | 106.61% |
| Denali Therapeutics Inc. | -145.22 Million USD | -64.737% |
| Revelation Biosciences, Inc. | -120.25 Thousand USD | -198843.902% |
| Veru Inc. | -93.15 Million USD | -156.823% |
| Corvus Pharmaceuticals, Inc. | -27.02 Million USD | -785.116% |
| Cingulate Inc. | -23.53 Million USD | -916.522% |
| Passage Bio, Inc. | -102.06 Million USD | -134.405% |
| Context Therapeutics Inc. | -23.96 Million USD | -898.314% |
| Exicure, Inc. | -16.91 Million USD | -1314.438% |
| Day One Biopharmaceuticals, Inc. | -188.91 Million USD | -26.637% |
| Oramed Pharmaceuticals Inc. | -37.76 Million USD | -533.508% |
| Scinai Immunotherapeutics Ltd. | -6.5 Million USD | -3576.442% |
| Rhythm Pharmaceuticals, Inc. | -184.67 Million USD | -29.543% |
| Nuvalent, Inc. | -126.21 Million USD | -89.542% |
| ABVC BioPharma, Inc. | -10.51 Million USD | -2175.065% |
| Carisma Therapeutics, Inc. | -86.87 Million USD | -175.369% |
| Unicycive Therapeutics, Inc. | -30.54 Million USD | -683.257% |
| OmniAb, Inc. | -50.61 Million USD | -372.625% |
| Anew Medical, Inc. | 1.34 Million USD | 17872.347% |
| Fennec Pharmaceuticals Inc. | -16.04 Million USD | -1391.044% |
| Lipocine Inc. | -16.35 Million USD | -1363.043% |
| Lexeo Therapeutics, Inc. Common Stock | -66.39 Million USD | -260.331% |
| Nautilus Biotechnology, Inc. | -63.67 Million USD | -275.717% |
| SAB Biotherapeutics, Inc. | -42.19 Million USD | -466.998% |
| G1 Therapeutics, Inc. | -47.96 Million USD | -398.755% |
| Bellerophon Therapeutics, Inc. | -19.83 Million USD | -1106.384% |
| Sage Therapeutics, Inc. | -541.48 Million USD | 55.818% |
| Ocugen, Inc. | -63.07 Million USD | -279.273% |
| Mind Medicine (MindMed) Inc. | -95.73 Million USD | -149.904% |
| Q32 Bio Inc. | -112.96 Million USD | -111.788% |
| Brainstorm Cell Therapeutics Inc. | -17.19 Million USD | -1291.566% |
| Alumis Inc. Common Stock | -154.99 Million USD | -54.354% |
| Equillium, Inc. | -13.33 Million USD | -1694.061% |
| Kyverna Therapeutics, Inc. | -60.36 Million USD | -296.312% |
| Coya Therapeutics, Inc. | -7.98 Million USD | -2895.029% |
| CNS Pharmaceuticals, Inc. | -18.85 Million USD | -1169.085% |
| Galera Therapeutics, Inc. | -59.08 Million USD | -304.925% |
| Evelo Biosciences, Inc. | -114.52 Million USD | -108.892% |
| Comera Life Sciences Holdings, Inc. | -18.37 Million USD | -1201.766% |
| Dominari Holdings Inc. | -22.88 Million USD | -945.529% |
| Edesa Biotech, Inc. | -8.37 Million USD | -2756.773% |
| vTv Therapeutics Inc. | -20.25 Million USD | -1081.422% |
| Bio-Techne Corporation | 168.1 Million USD | 242.315% |
| Agios Pharmaceuticals, Inc. | -352.08 Million USD | 32.052% |
| Harmony Biosciences Holdings, Inc. | 128.85 Million USD | 285.667% |
| Prelude Therapeutics Incorporated | -121.83 Million USD | -96.367% |
| Candel Therapeutics, Inc. | -37.93 Million USD | -530.586% |
| iTeos Therapeutics, Inc. | -112.64 Million USD | -112.388% |
| Nkarta, Inc. | -117.5 Million USD | -103.605% |
| BioCardia, Inc. | -11.57 Million USD | -1967.565% |
| Iterum Therapeutics plc | -38.37 Million USD | -523.486% |